Clinical trial
Factors Affecting PrEP Adherence
NCT02411630
Study timeline
Study start (unknown)2013-06-01Date precision: month
Registry last updated2017-02-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV Infectionunresolved
Interventions
Sponsors & collaborators
University of North Carolina, Chapel Hilllead sponsor
National Institute on Drug Abuse (NIDA)collaborator
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1TampaFlorida, United States1AuroraColorado, United States1DetroitMichigan, United States1New OrleansLouisiana, United States1MemphisTennessee, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02411630 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.